Projections of global mortality and burden of disease from, PLoSmed, vol.3, issue.11, p.442, 2002. ,
Effect of hémoglobin variants and chemically modified derivatives on assays for glycohemoglobin, Clin chem, vol.47, pp.153-63, 2001. ,
Diabetes control and complications: the role of glycated haemoglobin, 25 years on, Diabetic Medicine, vol.323, issue.7, pp.657-65, 2004. ,
DOI : 10.1001/jama.280.17.1490
Journée de fmc regionale Bejaïa, 29 Juin, 2013. ,
A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan (EPIDIAR) study. Diabetes Care, pp.2306-2317, 2004. ,
Recommendations for Management of Diabetes during Ramadan, update 2010, Diabetes Care, vol.33, issue.8, p.1895, 2010. ,
South Asian Guidelines for management of endocrine disorders in ramadan, Indian Journal Endocrinol Metab, vol.16, issue.4, pp.499-502, 2012. ,
Evolution de l'hémoglobine glyquée au cours du jeûne du mois de ramadan chez les diabétiques de type 2 traités par antidiabétiques oraux. Faculté de médecine de Tours, 2008. ,
Epid92-APLSG/réseau diabète92. 28 sept, 2006. ,
The effect of Ramadan fasting on well-being and attitudes toward diabetes in patients with diabetes, European Diabetes Nursing, vol.67, issue.1, pp.79-85, 2006. ,
DOI : 10.1002/pdi.767
A comparaison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during ramadan fasting. Diabetes research and clinical practice, pp.141-147, 2007. ,
Hémoglobine glyquée: mise au point et nouveautés, Revue Médicale Suisse, issue.68, 2006. ,